-

SynergenX Network Clinics Expand Peptide Therapy Options with BPC-157 and CJC-1295 + Ipamorelin

New treatments available October 6, 2025 at SynergenX, Low T Center, and HerKare

HOUSTON--(BUSINESS WIRE)--SynergenX, veteran-owned leader in personalized hormone and wellness medicine, is expanding its peptide therapy program with the addition of BPC-157 and CJC-1295 + Ipamorelin, two popular new peptide therapies that allow patients to pursue natural, rejuvenating option for health optimization, alone or in addition to hormone and weight-loss therapies. Beginning October 6, 2025, patients across SynergenX, Low T Center, and HerKare locations will have access to these advanced medical treatments, which build on the clinics’ existing use of peptide therapies such as Sermorelin.

SynergenX Network Clinics Expand Peptide Therapy Options

Share

“Peptides are a natural extension of the work we already do in hormone and wellness medicine,” said Wayne Wilson, Founder and CEO of SynergenX. “By expanding our peptide therapies we’re giving patients cutting-edge resources to recover, restore, and thrive so they can achieve s higher quality of life.”

BPC-157: The Body Protection Peptide

BPC-157 is known for accelerating recovery in muscles, tendons, and ligaments, making it ideal for patients healing from injuries or surgery, managing chronic joint pain, or seeking relief from inflammation. Benefits may include faster recovery, reduced pain, and possible gastrointestinal protection.

CJC-1295 + Ipamorelin: The Vitality Amplifier

This peptide combination stimulates natural growth hormone release to support energy, recovery, and healthy aging. Potential benefits include improved muscle repair, enhanced metabolism, body composition support, and regenerative effects without direct hormone replacement.

Why Choose SynergenX Network Clinics?

SynergenX has built its reputation on patient-focused care. Every peptide therapy program is:

  • Supervised by licensed providers with expertise in regenerative and hormone medicine
  • Personalized through lab work, diagnostics, and health goals
  • Supported by ongoing follow-up to ensure safety and sustainable results

The addition of these new peptide therapies gives patients more options than ever, and further cements SynergenX’s place as a leader in the health and wellness industry. Appointments for BPC-157 and CJC-1295 + Ipamorelin begin October 6, 2025.

About SynergenX

SynergenX is a veteran-owned, patient-focused provider specializing in hormone therapy and wellness care for men and women. With multiple nationwide locations, the SynergenX network helps patients restore balance, improve vitality, and achieve a better quality of life.

Contacts

Media Contact:
Jordan Bailey
Marketing Communications Specialist, SynergenX / Low T Center
8326391569
jbailey@synergenxhealth.com

Industry:

SynergenX

Release Versions
English

Contacts

Media Contact:
Jordan Bailey
Marketing Communications Specialist, SynergenX / Low T Center
8326391569
jbailey@synergenxhealth.com

Social Media Profiles
Instagram
More News From SynergenX

SynergenX Opens New Tyler Clinic with Grand Opening Celebration

TYLER, Texas--(BUSINESS WIRE)--SynergenX, the largest provider of both in-clinic and telemedicine hormone optimization services, continued its strategic growth with the opening of its newest clinic in Tyler, expanding access to personalized, provider-led hormone optimization and wellness care for East Texas residents. The new location reflects SynergenX's continued investment in meeting the growing demand for comprehensive wellness services. The Tyler clinic offers testosterone replacement ther...

SynergenX Launches "Know Your Baseline" Initiative to Expand Access to Personalized Women's Hormone Care

HOUSTON--(BUSINESS WIRE)--SynergenX today announced the launch of Know Your Baseline, a new initiative designed to help women better understand their hormone health through comprehensive testing, personalized treatment, and collaborative care. While hormone conversations often begin during perimenopause, many women experience symptoms such as fatigue, low libido, brain fog, mood changes, poor recovery, weight changes, and difficulty building muscle years earlier. Whether those symptoms are rela...

SynergenX Launches "$250 for 250" Initiative to Expand Access to Personalized TRT

HOUSTON--(BUSINESS WIRE)--SynergenX, rapidly-growing leader in optimized hormone health and weight loss, is commemorating America's 250th anniversary with its "250 for 250" initiative, a limited-time promotion designed to make personalized testosterone replacement therapy (TRT) and hormone replacement therapy (HRT) more accessible while encouraging men and women to invest in their long-term health.Throughout July, eligible new male and female patients who begin TRT at a SynergenX, Low T Center,...
Back to Newsroom